ChemomAb Competitors and Similar CompaniesClear all
Autolus's competitors and similar companies include Inozyme and Altimmune.
 Autolus Autolus Therapeutics is a private biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products. |  Inozyme Inozyme is a biotechnology company that develops medicines to treat rare diseases of calcification. | ||
Founding Date | Founding Date 2014 | Founding Date 2016 | Founding Date 1997 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations London, GB HQ London, GB | Locations Boston, US HQ Boston, US Boston, US | Locations Gaithersburg, US HQ |
Employees | Employees 647 | Employees 653% increase | Employees 691% increase |
Valuation ($) | Valuation ($) 1.2 b | Valuation ($) 310 m | Valuation ($) 498.2 m |
Financial | |||
Revenue (est.) | Revenue (est.) $75.4m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $41k (FY, 2025) |
Net income | Net income ($287.5m) (FY, 2025) | Net income ($102m) (FY, 2024) | Net income ($88.1m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 281.7m | Total funding raised $ 116m | Total funding raised $ 47.7m |
For sources of this data, please see the company profile
View Company Profiles
Inozyme
HQ
Boston, US
Employees
65↑ 3% increase
Inozyme is a biotechnology company that develops medicines to treat rare diseases of calcification.
View company
Altimmune
HQ
Gaithersburg, US
Employees
69↑ 1% increase
Altimmune is a clinical-stage immunotherapeutics company.
View company